| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |